Provider of integrated drug development platform designed to support drug and device development. The company's integrated drug development platform automates workflows and provides advanced content management within a secure, web-based environment.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Out of Business | 01-Apr-2016 | 00.000 | Completed | Out of Business | ||
3. Convertible Debt | 02-Jul-2008 | 00000 | 00.000 | Completed | Startup | |
2. Grant | 23-Jun-2006 | $162K | $2.23M | Completed | Startup | |
1. Early Stage VC | 02-Apr-2006 | $2.23M | $2.23M | Completed | Startup |
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-7407646-B2 | Hydrophilic polymer, and superparamagnetic iron oxide particles complexed with a second hydrophilic polymer | Expired - Lifetime | 25-Apr-2000 | 00000000 | 0 |
ES-2248318-T3 | Biomaterial based on hydrophyl polymer that presents a specific sign in images by magnetic resonance and procedure for preparation of such biomaterial. | Expired - Lifetime | 25-Apr-2000 | 00000000 | |
DE-60113089-D1 | Biomaterial based on a hydrophilic polymer with a special signal in magnetic resonance and method for the production thereof | Expired - Lifetime | 25-Apr-2000 | 00000000 | |
US-20030077225-A1 | Hydrophilic polymer, and superparamagnetic iron oxide particles complexed with a second hydrophilic polymer | Granted | 25-Apr-2000 | 00000000 | 0 |
AU-5640501-A | Biomaterial based on hydrophilic polymer exhibiting a specific signal in magnetic resonance imaging and method for preparing same | Pending | 25-Apr-2000 | C08K9/08 |
Name | Representing | Role | Since |
---|---|---|---|
Matthew Morgan | Self | Board Member | 000 0000 |
Steven Godinho | Xbio Systems | Board Member & Chief Executive Officer | 000 0000 |